Results 141 to 150 of about 4,653 (155)

Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension

International Journal of Pharmaceutics, 2015
Sarasija Suresh
exaly  

Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects

British Journal of Clinical Pharmacology, 2008
Reza Khosravan
exaly  

Polymorphs of Febuxostat

2015
HOTTER ANDREAS, GRIESSER ULRICH, ADAMER VERENA, LANGES CHRISTOPH   +3 more
openaire   +2 more sources

Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment

Joint Bone Spine, 2016
Pierre Clérson, Thomas Bardin, Tristan Pascart   +2 more
exaly  

Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients With or Without Gout: A Systematic Review and Meta-Analysis

Clinical Therapeutics, 2013
Qifu Li, Qingfeng Cheng, Shumin Yang
exaly  

Crystalline forms of Febuxostat

2010
PIRAN MAYTAL, METSGER LEONID
openaire   +6 more sources

A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout

Seminars in Arthritis and Rheumatism, 2013
Joanne Homik, Marcello Tonelli, Natasha Wiebe   +2 more
exaly  

Febuxostat for the treatment of hyperuricaemia in gout

Expert Opinion on Pharmacotherapy, 2018
Philip Robinson, Nicola Dalbeth
exaly  

A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia

International Journal of Rheumatic Diseases, 2015
Yongde Peng, Qiuhe Ji, Xiangyang Liu
exaly  

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

Life Sciences, 2005
exaly